Food and Drug Administration

Legislation moving through Congress on medical devices suggests broader lessons for how to improve the cybersecurity of essential products and critical infrastructure. The bill’s proposed system of regulation and oversight holds promise for meeting the competing criteria of certainty and flexibility, stability and adaptability, mandate and innovation.